Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment

نویسندگان

چکیده

Until the recent introduction of direct-acting antiviral (DAA) medications, only available hepatitis C treatments were lengthy and onerous interferon-based therapies, with relatively weak success rates. While experiences treatment have been well documented, there is a need to better understand how ‘old’ shape contemporary experiences. This article uses concept ‘post-crisis’ developed in critical scholarship on HIV/AIDS, theorisations ‘curative time’, explore relationship between legacies therapies. In mobilising these concepts, we trouble linear temporal logics that take for granted distinctions past present, old new, cure post-cure, draw attention fluidity time overlapping co-constitutive terrains meaning Drawing 50 interviews people affected by C, argue curative imaginary DAA – is, framing applied which expected assumed shaped logic crisis. Here, knowledge possibilities new living remain tethered crisis accounts interferon. Unlike disease itself was figured as crisis, many participants described crisis: worse than C. widely simple easy, not so straightforward crisis/post-crisis relation central this complexity . We conclude considering significance post-crisis enactments understanding plateauing uptake, reflect futures ‘cure’ address ongoing constitutive effects treatments.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

New treatment of hepatitis C (Direct Acting Antiviral)

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for the patients with HCV-related liver disease has advanced considerably thanks to an enhanced understanding of the pathophysiology of the disease, and because of developments in diagnostic procedures and improvements in therapy an...

متن کامل

Direct-acting antiviral agents in patients with hepatitis C cirrhosis.

Patients with cirrhosis who are infected with hepatitis C virus (HCV) are the most in need of antiviral treatment. Virologic cure improves fibrosis and quality of life while reducing liver-related morbidity and mortality. In mid-2011, the addition of direct-acting antiviral agents (DAAs)-the protease inhibitors boceprevir (Victrelis, Merck) and telaprevir (Incivek, Vertex)-to pegylated interfer...

متن کامل

Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy.

Hepatitis C therapy in the era of the newer direct-acting antiviral agents has radically changed our treatment schemes by achieving very high rates of sustained virological response. However, treatment with direct antiviral agents fails in a subgroup of patients. This group of so-called difficult-to-treat individuals is the subject of this paper, which reviews the causes of virological failure,...

متن کامل

Simplified diagnostic monitoring for hepatitis C, in the new era of direct-acting antiviral treatment.

PURPOSE OF REVIEW Approximately 150-175 million people are infected with hepatitis C virus (HCV). Until very recently, the complexity, cost and poor efficacy and tolerability of pegylated interferon and ribavirin (PEG-RBV) treatment have hindered scale up in low-income and middle-income countries (L&MICs). Similarly, the diagnostic and monitoring algorithm associated with PEG-RBV has been expen...

متن کامل

Direct-acting antiviral medications for chronic hepatitis C virus infection.

Treatment of hepatitis C virus has traditionally been difficult because of low rates of treatment success and high rates of treatment discontinuation due to side effects. Current standard therapy consists of pegylated interferon α and ribavirin, both of which have nonspecific and largely unknown mechanisms of action. New therapies are in development that act directly on the hepatitis C virus at...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Time & Society

سال: 2022

ISSN: ['1461-7463', '0961-463X']

DOI: https://doi.org/10.1177/0961463x221128736